Résumé
AIM: To evaluate the efficacy and the safety of betamethasone neomycin ointment in treatment of patients with subacute eczema. METHODS: The clinical trial was performed on patients with limited, subacute eczema by a randomized double blind method. Hydrocortisone neomycin ointment was chosen as controls. RESULTS: There were 45 patients involved in this study, including 23 patients in betamethasone neomycin ointment group and 22 patients in hydrocortisone neomycin ointment group. The total integra decrease of betamethasone neomycin ointment group [ 12.26 ? 2.42 to 5.61 ? 2.23 ( d 7 ), 2.83 ? 2.06 ( d 14 )] was better than that of hydrocortisone neomycin ointment group [ 13.18 ? 2.28 to 9.18 ? 3.72 ( d 7 ), 6.82 ? 3.46 ( d 14 )] on the 7th and 14th day after the treatment (P